234 (PB222): Rational combination of pan-TEAD inhibitor SW-682 and MEK inhibitor mirdametinib in head and neck squamous cell carcinomas leads to synergistic response

Saved in:

Bibliographic Details
Published in	European journal of cancer (1990) Vol. 211; p. 114752
Main Authors	Schirmer, A., Chen, L., Celentano, L., Chanelo, A., Jove, V., DuBose, R., Saha, S., Johnson, M., Lawhorn, B., Gwaltney, S., Lin, T.A., de Marval, P. Miliani
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.10.2024
Online Access	Get full text

Loading…

More Information
ISSN:	0959-8049
DOI:	10.1016/j.ejca.2024.114752